Deliberating Tarceva: A case study of how British NHS managers decide whether to purchase a high-cost drug in the shadow of NICE guidance

Social Science and Medicine

Volumn 73, Issue 10, 2011, Pages 1460-1468

  Hughes, David ^a   Doheny, Shane ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Decision making; Habermas; High cost drugs; Managers; NHS commissioners; NICE guidance; Rationing; UK; Wales

Indexed keywords

DOCETAXEL; ERLOTINIB; LENALIDOMIDE; SUNITINIB; TRABECTEDIN;

CANCER; COST-BENEFIT ANALYSIS; DECISION MAKING; DISEASE TREATMENT; DRUG; DRUG PRESCRIBING; GUIDELINE; HEALTH WORKER;

ARTICLE; CLINICAL EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISCOURSE ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG PREFERENCE; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FINANCING; HUMAN; LUNG NON SMALL CELL CANCER; MANAGER; MEDICAL DECISION MAKING; NATIONAL HEALTH ORGANIZATION; NATIONAL HEALTH SERVICE; NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE; OUTCOME ASSESSMENT; PHARMACIST; POPULATION RESEARCH; PRACTICE GUIDELINE; PUBLIC HEALTH; PURCHASING; RISK BENEFIT ANALYSIS; STANDARDIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PHARMACOPOEIAS AS TOPIC; PROTEIN KINASE INHIBITORS; QUINAZOLINES; STATE MEDICINE; TAPE RECORDING;

UNITED KINGDOM;

EID: 80955145692     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2011.08.023     Document Type: Article

References (32)

1. Anspach R.R. Notes on the sociology of medical discourse: the language of case presentation. Journal of Health and Social Behavior 1988, 29:357-375.
2. Appleby J., Gregory S. NHS spending - local variations in priorities: an update 2008, The King's Fund, London.
3. Atkinson P. Medical talk and medical work: the liturgy of the clinic 1995, Sage, London.
4. Aylward M. An independent appeals model for individual patient commissioning in Wales 2008, Welsh Centre for Health, Cardiff.
5. BBCNews Cancer drug access varies widely 2008, Available online at, (accessed 17 August 2010). mailto:http://news.bbc.co.uk/2/hi/health/7625102.stm.
6. Bogen D. Order without rules: critical theory and the logic of conversation 1999, SUNY Press, Albany, New York.
7. Cicourel A.V. The social organisation of juvenile justice 1968, Wiley, New York.
8. Chriss J.J. Habermas, Goffman, and communicative action: implications for professional practice. American Sociological Review 1995, 60:545-565.
9. Department of Health Good practice guidance on managing the introduction of new healthcare interventions and links to NICE technology appraisal guidance 2006, Department of Health, London, Available at, (accessed August 15 2010). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_064983.
10. Devlin N., Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? a binary choice analysis. Health Economics 2004, 13:437-452.
11. Dobson F. Speech launching NICE 1999, Available online at, NICE (accessed 17 August 2010). http://www.nice.org.uk/aboutnice/whatwedo/niceandthenhs/secretary_of_states_speech_launching_nice.jspaunching.
12. Griffiths L., Hughes D. Innocent parties" and "disheartening" experiences: natural rhetorics in neuro-rehabilitation admissions conferences. Qualitative Health Research 1994, 4:385-410.
13. Goffman E. Frame analysis: An essay on the organization of experience 1974, Harvard University Press, Cambridge, MA.
14. Habermas J. The theory of communicative action 1984, Polity Press, Cambridge.
15. Habermas J. Communication and the evolution of society 1991, Polity Press, Cambridge.
16. Hughes D., Griffiths L. "But if you look at the coronary anatomy.": risk and rationing in cardiac surgery. Sociology of Health and Illness 1996, 18:172-197.
17. Hunter D.J. Rationing health care: the political perspective. British Medical Bulletin 1995, 51:876-884.
18. Jones M., Irvine B. NICE OR NASTY: Has NICE eliminated the 'postcode lottery' in the NHS? 2003, Civitas Health Unit, London, Available online at, (accessed 17 August 2010). http://www.civitas.org.uk/pdf/NICE.pdf.
19. Klein R., Day P., Redmayne S. Managing scarcity: priority setting and rationing in the national health Service 1996, Open University Press, Buckingham.
20. Laurance J. NHS watchdog is winning the price war with drug companies. The Independent 2009, 21 December.
21. Mechanic D. Muddling through elegantly: finding the proper balance in rationing. Health Affairs 1997, 16:83-92.
22. Erlotinib for the treatment of non-small-cell lung cancer - appraisal consultation document 2008, NICE, Available online at, (accessed 17 August 2010). http://www.nice.org.uk/guidance/index.jsp%3Faction%3darticle&o%3d39164.
23. Erlotinib for the treatment of non-small-cell cancer - final appraisal determination 2008, NICE, Available online at, (accessed 17 August 2010). http://www.nice.org.uk/guidance/index.jsp%3Faction%3ddownload%26o%3d42154.
24. TA 162: lung cancer (non-small-cell) - Erlotinib: technology appraisal (November) 2008, NICE, Available online at, (accessed 17 August 2010). http://guidance.nice.org.uk/TA162/Guidance/pdf/English.
25. Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy) - final appraisal determination 2011, NICE, Available online at, (accessed 25 June 2011). http://guidance.nice.org.uk/TA/Wave19/55/FAD.
26. NICE website (n.d.). What we do. Available online at (accessed 17 August 2010). http://www.nice.org.uk/aboutnice/whatwedo/abouttechnologyappraisals/about_technology_appraisals.jsp.
27. Poole T. NICE technology appraisals: briefing 2008, The King's Fund, London.
28. Richards M. Improving access to medicines for NHS patients: a report for the Secretary of State for health by Professor Mike Richards 2008, Department of Health, London, Available at, (accessed on 5 November 2008). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089927.
29. Shepherd F.A., Pereira J.R., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., et al. Erlotinib in previously treated non-small-cell lung cancer. New England Journal of Medicine 2005, 353:123-132.
30. Silverman D. Communication and medical practice: social relations in the clinic 1987, Sage, London.
31. Strong P.M. The ceremonial order of the clinic 1983, Routledge, London.
32. Strydom P. Discourse and knowledge: the making of enlightenment sociology 2000, Liverpool University Press, Liverpool.